Prosecution Insights
Last updated: October 04, 2026
Application No. 18/858,637

METHOD FOR AUTOMATICALLY DETERMINING A SET OF AT LEAST ONE OPTIMAL CHARACTERISTIC PARAMETER OF A MAGNETIC RESONANCE ACQUISITION SEQUENCE

Non-Final OA §112
Filed
Oct 21, 2024
Priority
Apr 22, 2022 — FR FR2203766 +1 more
Examiner
BYKHOVSKI, ALEXEI
Art Unit
Tech Center
Assignee
Centre Hospitalier Universitaire Vaudois
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
10m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
298 granted / 386 resolved
+17.2% vs TC avg
Strong +26% interview lift
Without
With
+25.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
24 currently pending
Career history
421
Total Applications
across all art units

Statute-Specific Performance

§101
6.7%
-33.3% vs TC avg
§103
51.2%
+11.2% vs TC avg
§102
13.2%
-26.8% vs TC avg
§112
25.1%
-14.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 386 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 6-7 and 9 are objected to because of the following informalities: In claims 6-7, the “characteristic images” should read – the characteristic images–. In claim 7, line 3, the “signals” should read –the signals–. In claim 9, line 4, the “a medical acquisition sequence” should read –the medical signal acquisition sequence–. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 1 recites the "at least one characteristic parameter” in line 3 from the end. It is unclear whether or not this recitation refers to the "at least one characteristic parameter” in line 2. For examination purposes, Examiner of record takes this to be “the at least one characteristic parameter”. Claim 4 recites "the characteristic set” in line 2. It is unclear whether or not this recitation refers to the "optimal characteristic set” in Claim 1, line 1. For examination purposes, Examiner of record takes this to be “the optimal characteristic set”. Claim 9 recites "the optimal set of at least one characteristic parameter” in lines 2-3. It is unclear whether or not this recitation refers to the "optimal characteristic set” in Claim 1, line 1 and to the "at least one characteristic parameter” in Claim 1, line 2. For examination purposes, Examiner of record takes this to be “the optimal characteristic set of the at least one characteristic parameter”. Claims 11 and 13 recite "the steps of the method according to claim 1” in lines 3 and 4, respectively. This recitation is unclear because only one step, the “selecting”, is recited in the method according to claim 1. For examination purposes, Examiner of record takes this to be “the method according to claim 1”. Claims dependent upon the rejected claims above, but not directly addressed, are also rejected because they inherit the indefiniteness of the claim(s) they respectively depend upon. Allowable Subject Matter Claims 1-13 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXEI BYKHOVSKI whose telephone number is (571)270-1556. The examiner can normally be reached on Monday-Friday: 8:30am - 5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Pascal Bui Pho can be reached on 571-272-2714. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEXEI BYKHOVSKI/ Primary Examiner, Art Unit 3798
Read full office action

Prosecution Timeline

Oct 21, 2024
Application Filed
Sep 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745989
MEDICAL IMAGING METHOD, MEDICAL IMAGING SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM
2y 2m to grant Granted Sep 29, 2026
Patent 12745908
SYSTEMS AND METHODS UTILIZING RAMAN SPECTROSCOPY FOR IN VIVO ANALYSIS
1y 9m to grant Granted Sep 29, 2026
Patent 12740764
ULTRASOUND DIAGNOSTIC APPARATUS, ULTRASOUND DIAGNOSTIC METHOD, AND RECORDING MEDIUM
1y 10m to grant Granted Sep 22, 2026
Patent 12728279
PHOTOTHERAPY PLANNING DEVICE AND PHOTOTHERAPY PLANNING METHOD
2y 11m to grant Granted Sep 08, 2026
Patent 12727862
ULTRASOUND IMAGE ARTEFACT REDUCTION
1y 10m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
99%
With Interview (+25.9%)
2y 9m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 386 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month